Quote | Virpax Pharmaceuticals Inc. (NASDAQ:VRPX)
Last: | $2.23 |
---|---|
Change Percent: | 5.12% |
Open: | $2.41 |
Close: | $2.23 |
High: | $2.5 |
Low: | $2.105 |
Volume: | 40,171 |
Last Trade Date Time: | 05/02/2024 03:00:00 am |
News | Virpax Pharmaceuticals Inc. (NASDAQ:VRPX)
-Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief- Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post...
2024-04-18 16:45:28 ET More on Virpax Pharmaceuticals Scilex and Sorrento settle with Virpax and its founder Anthony Mack Seeking Alpha’s Quant Rating on Virpax Pharmaceuticals Historical earnings data for Virpax Pharmaceuticals Financial information f...
Message Board Posts | Virpax Pharmaceuticals Inc. (NASDAQ:VRPX)
Subject | By | Source | When |
---|---|---|---|
znewcar1: VRPX HH36 Todays the LL2.46 It was halted last year @4.4 with an interesting 150K B>2.6 | znewcar1 | investorshangout | 01/21/2022 4:03:43 PM |
Litigation | StockLogistics | investorshub | 12/09/2021 12:20:45 PM |
News | Awl416 | investorshub | 12/08/2021 1:08:54 PM |
Adding here | JMoneyHoops | investorshub | 11/11/2021 12:40:46 PM |
Company just screwed existing share holders with a | ok2buy | investorshub | 09/14/2021 1:54:52 PM |
News, Short Squeeze, Breakout and More Instantly...
Virpax Pharmaceuticals Inc. Company Name:
VRPX Stock Symbol:
NASDAQ Market:
-Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief- Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indicat...